VARELISA B2 GLYCOPROTEIN I IGM ANTIBODIES, MODELS 18848 AND 18896— 510(k) K040451

Substantially Equivalent

Pharmacia Deutschland GmbH

FDA 510(k) clearance K040451 for VARELISA B2 GLYCOPROTEIN I IGM ANTIBODIES, MODELS 18848 AND 18896, Substantially Equivalent on 2004-05-11. Applicant: Pharmacia Deutschland GmbH.

Clearance details

Applicant
Pharmacia Deutschland GmbH
Product code
Code MSV
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Freiburg, DE
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.